Hood River Capital Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hood River Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $593,037 - $1.04 Million	7,133 Added 3.08%	238,670 $34.8 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $7.53 Million - $9.78 Million	-68,435 Reduced 22.81%	231,537 $27.5 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $21.4 Million - $31.8 Million	214,452 Added 250.76%	299,972 $41.3 Million
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $22.9 Million - $32.2 Million	-231,828 Reduced 73.05%	85,520 $11.9 Million
Q2 2021 Aug 13, 2021	SELL	$65.78 - $105.02 $311,731 - $497,689	-4,739 Reduced 1.47%	317,348 $30.8 Million
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $7.25 Million - $10.4 Million	113,141 Added 54.15%	322,087 $22 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $216,422 - $326,746	3,326 Added 1.62%	208,946 $17.9 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $1.22 Million - $1.61 Million	-20,662 Reduced 9.13%	205,620 $13.4 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $6.56 Million - $16.8 Million	226,282 New	226,282 $16.5 Million

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Hood River Capital Management LLC with notifications on news.